TGFB1 and renal fibrosis: Its mechanism of action may be with the inhibition of TGF-β/Smad signaling pathway and inhibiting the expression of extracellular matrix components, which in turn suppresses the production of CO-IV, LN and FN, thus achieving an deferment of renal fibrosis in diabetic rats.